Conclusions: #1 All upside from here #2. FDA should be embarrasssed
Got to just roll with FDA's sucker punch. Looks like option interest is still on the increase (Mar 16 calls) - a substantial increase since last friday. A good thing obviously. As for the FDA's actions, pretty embarrassing IMO. Especially after their very positive AdComm briefing. Were they not the ones who suggested the larger 18-70 age group? Anyone with more detail on age grouping rope-a-dope that FDA gave DVAX? Heplisav is going to be approved, just not today.
The FDA is just another useless tax dollar sucking government buearacracy that has a hard time justifying their existence other than covering their #$%$ Sort of like the SEC that was supposed to protect investors from the likes of Bernie Madoff